Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Gross Profit 2020–2023
Immuneering Corporation annual/quarterly gross profit history and growth rate from 2020 to 2023. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Immuneering Corporation gross profit for the quarter ending September 30, 2023 was 0, a 100.00% decrease year-over-year.
- Immuneering Corporation gross profit for the twelve months ending September 30, 2023 was 19037, a 97.44% decrease year-over-year.
- Immuneering Corporation annual gross profit for 2023 was 0, a 100.00% decrease from 2022.
- Immuneering Corporation annual gross profit for 2022 was 158830, a 82.86% decrease from 2021.
- Immuneering Corporation annual gross profit for 2021 was 926888, a 10.12% decrease from 2020.
- Immuneering Corporation annual gross profit for 2020 was 1.0 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Immuneering Corporation Gross Profit — FAQ
Immuneering Corporation (IMRX) gross profit over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's gross profit history?
The chart and table above show Immuneering Corporation's gross profit by year and by quarter, including the growth rate.